Deserved ridicule; from a horse of course. Column: A

New Post Public Reply Private Reply Replies (0) Message Board
Bhawks SaltyMutt #68438
188
Deserved ridicule; from a horse of course.

Column: A letter from a horse: Please stop taking ivermectin to treat COVID-19. That’s our medicine, you ninnies.

By REX HUPPKE
CHICAGO TRIBUNE |

AUG 27, 2021 AT 3:37 PM

E3EXSWRPF5BPHMOQQ7VL33B65A.jpg
A horse pokes his head out from a stall at Tukaway Farm in Elgin in 2017. (Stacey Wescott / Chicago Tribune)

Through my numerous sources in the animal kingdom, I received the following letter from a horse. He’s apparently upset about a new fad among COVID-19 vaccine conspiracists: using ivermectin, a livestock dewormer, as protection against or treatment for the virus.

While the U.S. Food and Drug Administration and other public health agencies have spoken out about the extreme wrongness of consuming an anti-parasitic livestock medication when a safe and effective coronavirus vaccine meant for humans is readily available, it seemed worth it to let this horse have his say and enter the following into the public conversation:

Greetings, humans.

You probably expected me to start this letter with “Howdy.” You two-legged types always associate horses with southerners and cowboys. For the record, that’s horse-ist and we don’t appreciate it. I’m from Schaumburg, for Seabiscuit’s sake.

Anyway, the reason I’m writing is to make a simple request on behalf of my fellow horses and livestock everywhere: Please stop taking ivermectin. You keep scooping the stuff up off shelves in farm stores all over creation and, frankly, we’re getting peeved. That’s our medicine, not yours.

You don’t see a bunch of cows strolling into CVS and buying up all the Benadryl, do you? Of course not. That’s partially because of unjust rules that prevent our kind from roaming freely and taking advantage of shopping centers, but it’s mainly because we’re smart enough to know we shouldn’t put human stuff in our nonhuman bodies.

We use ivermectin because we tend to get internal and external parasites, and that stuff knocks them out pretty well.

I recently needed some to treat my sarcoptic mange, but guess what? THE FARM SUPPLY STORE WAS OUT OF IVERMECTIN CAUSE A BUNCH OF YOU READ SOME HOO-HAH ON THE INTERNET AND DECIDED THE SMART MOVE WAS TO IGNORE YOUR DOCTORS AND TAKE SOME HORSE MEDICINE!!!

Unless you were suffering from sarcoptic mange, and are a horse, I’m going to have to ask you to return the ivermectin and stop believing everything you read.

I tried at first to send a note like this to some people in the human anti-vaccine/anti-mask/”COVID isn’t a big deal” community. But it didn’t go well.

I wanted to reach Phil Valentine, a conservative radio host and vaccine skeptic who promoted ivermectin to treat COVID-19, but was unable to because he died from COVID-19.

I wanted to reach Caleb Wallace, a 30-year-old Texas man who organized protests against pandemic restrictions and treated himself with ivermectin when he developed COVID-19 symptoms, but he’s on a ventilator in a Texas intensive care unit.

I wanted to reach H. Scott Apley, a Texas GOP official who spoke out against vaccines and showed support for a mask burning, but he was also unavailable due to dying from COVID-19.

Apparently the phrase “You can lead a horse to water, but you can’t make it drink” applies to humans as well.

So I’m sending this note out through the press in the hope it does some good.

Here are a few facts:

Ivermectin has been used to treat humans, but it’s not approved as a treatment for COVID-19, and two-legged medical professionals who are not snake-oil salespeople strongly advise against taking it for that purpose.

According to a human I had do research for me in exchange for free rides, the FDA’s website says: “Ivermectin tablets are approved at very specific doses for some parasitic worms, and there are topical (on the skin) formulations for head lice and skin conditions like rosacea. Ivermectin is not an antiviral (a drug for treating viruses). Taking large doses of this drug is dangerous and can cause serious harm.”

The FDA says side effects can include nausea, vomiting, diarrhea, facial or limb swelling, seizures and liver injury.

According to a recent health advisory from the U.S. Centers for Disease Control and Prevention, here’s one example of what happened when a human took ivermectin and then called poison control because — SURPRISE! — illness ensued: “An adult drank an injectable ivermectin formulation intended for use in cattle in an attempt to prevent COVID-19 infection.

This patient presented to a hospital with confusion, drowsiness, visual hallucinations, tachypnea, and tremors. The patient recovered after being hospitalized for nine days.”

The FDA summed up this weird situation effectively in a recent tweet: “You are not a horse. You are not a cow. Seriously, y’all. Stop it.”

I am a horse, and I would like to reiterate that last point: Stop it. You’re making cows look smart. (Sorry. I had to slip a cow burn in here somewhere. Trust me, they’ll appreciate it.)

Look, I appreciate most of you guys, and thanks for all the oats and hay and whatnot. But you really need to come to your senses.
You don’t want to wear a mask? Well, guess what, I don’t want to constantly swish my tail around to keep flies off my rear end. But I do it.

And if somebody came along and said, “Hey, if you take this human medicine that’s not approved for horses and probably doesn’t work, you might never have to swish your tail again, although you might die from diarrhea …”

You know what I’d do? I’D KEEP SWISHING MY DANG TAIL BECAUSE IT’S REALLY NOT THAT BIG A DEAL!!


Anyhoo, I’ve taken up enough of your time. Please get your shots and keep your weird sausage fingers off our ivermectin.
— A horse

https://www.chicagotribune.com/columns/rex-hu...story.html
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Tessa AI: Revolutionizing Biomedical Research with AI

Updated Category News Views 0

Shaking Up Research Evaluation When Siensmetrica decided it was high time for a name change, morphing into Tessa AI wasn't just a cosmetic shift. It was a nod to what stakeholders were already calling it and laid the ground for a broader mission statement. They're not sitting on their hands; they're crafting tools that tackle the scientific life cycle from start to...

Continue Reading
Gourmia Introduces Ceramic-Coated Air Fryer at Costco

Updated Category News Views 3

A New Era for Home Cooking with Gourmia Stepping into the kitchen appliances arena with a dash of innovation, Gourmia has launched its first ceramic-coated air fryer, and it’s weaving its way exclusively onto the shelves of Costco. Now, it’s not just about frying anymore; it’s about adding style, efficiency, and a touch of healthy living to your countertop. But much...

Continue Reading
Maven Pet's AI Paw-tnership: Changing Pet Care Landscape

Updated Category News Views 19

AI in the World of Doggie Docs In today's tech-driven world, pet owners are turning to artificial intelligence like never before. Forget flipping through outdated dog-care books—nearly half of us are drilling ChatGPT for health tips on our four-legged pals. Yes, it seems we’re asking an AI about Rover's health more than some other major life decisions. But let's face...

Continue Reading
Truck Drivers USA & Career Driver Unveil New Driver Agent

Updated Category News Views 9

Revolutionizing Driver-Carrier Connections In today's cranking transportation scene, Truck Drivers USA (TDUSA) and Career Driver have taken a bold step to change up the driver recruitment game. They've launched what's being labeled as the first 'driver agent' within the Career Driver mobile app. It's the talk of the town in Sherwood, Arkansas, these days. This isn't just...

Continue Reading
Laars Welcomes Women in Manufacturing to Facility Tour

Updated Category News Views 15

Opening Doors and Minds in Manufacturing On October 15, Laars Heating Systems throws wide open its Rochester, N.H., facility to a group that's rewriting the rulebook: women in manufacturing. It's not just another day in the life of assembly lines and engineering desks, folks. This is about giving a platform to those often sidelined in the field of boilers and water...

Continue Reading
Oracle Announces AI-Driven QuickStart Platform Launch

Updated Category News Views 3

NetSuite's AI-First Step into the Market Well, here's the NYSE stirring the pot with Oracle NetSuite's fresh announcement—an AI-first platform called QuickStart. Sounds like they've got their sights set on early-stage tech startups, banking on those little guys to plug into AI tools they've already got in their toolkit. Claude, ChatGPT—these aren't new kids on the...

Continue Reading
Paradigm Therapeutics: A Beacon in Rare Diseases

Updated Category News Views 4

A Step Towards Recognition You know the old saying: innovation never sleeps. Well, Paradigm Therapeutics seems to have taken that to heart. The company's embarked on a peculiar yet promising journey with SD-101 (Zorblesia™), and here they are, basking in the glow of another nomination for the 2026 Prix Galien USA "Best Start-Up" award. It’s their second shot at this...

Continue Reading
FCS Drives Key FDA Approvals in Cancer Treatment

Updated Category News Views 6

Florida Cancer Specialists: Changing the Cancer Treatment Game Some organizations toot their horns, but every now and then, a group truly shakes up the playing field. Take Florida Cancer Specialists & Research Institute (FCS), for instance. Over years of relentless research, FCS has nailed its role in securing two significant FDA approvals aimed at expanding treatment...

Continue Reading
Franco-Nevada's Q3 Results Loom: Investors Ready

Updated Category News Views 29

Gearing Up: Franco-Nevada's Q3 Numbers on the Horizon You know the drill! Franco-Nevada's third quarter results won't just trickle in—they'll set the tone for the months ahead. Mark your calendar: November 11th after the market closes is the magic hour when you'll get the skinny on their Q3 performance. The next morning, bright and early at 8:00 AM ET, they'll hash it...

Continue Reading
Simple Home Upgrades That Boost Value Fast

Updated Category News Views 20

Transform Your Home's Curb Appeal Without Breaking The Bank Every homeowner knows that feeling when you look at your house one day and think, "This could use a little something." Say you're strolling through a neighborhood in Fulton, N.Y., and notice a gem. It's not a brand new build, but it gleams with character. You bet it's had a few smart touches that could apply...

Continue Reading

Top 5 Most Recently Viewed Articles

Kalmar Strengthens Ties with New Terminal Tractor Orders

Updated Category News Views 181

Kalmar and Cagliari RoRo Terminal: A Partnership in Progress Kalmar Corporation has recently sealed a significant agreement with Cagliari RoRo Terminal to enhance operational efficiency by supplying a total of eight heavy terminal tractors. This order, logged in Kalmar’s second quarter 2025 intake, is set to be delivered in the fourth quarter of 2025, marking another...

Continue Reading
Revolutionizing Healthcare: Rocket Doctor Wins Clinical Innovator Award

Updated Category News Views 162

Rocket Doctor Emerges as Clinical Innovator of the Year Rocket Doctor has garnered significant recognition for its innovative contributions to the field of digital healthcare. During the prestigious Innovators Challenge at NEXUS 2025, the company was honored as the Clinical Innovator of the Year. This acknowledgment reflects Rocket Doctor's commitment to transforming...

Continue Reading
Impressive Earnings Growth for Ohio Valley Banc in Q1 2025

Updated Category News Views 252

Ohio Valley Banc Corp. Reports Strong Earnings Performance In a notable financial update, Ohio Valley Banc Corp. (NASDAQ: OVBC) has unveiled its impressive consolidated net income for the quarter ending March 31, showcasing a remarkable growth. This rise reflects an increase of $1,613,000, equivalent to 57.8%, compared to the same quarter the previous year, with a total...

Continue Reading
Reviva Pharmaceuticals Achieves Key Milestones in 2025

Updated Category News Views 138

Reviva Pharmaceuticals Reports Progress on Brilaroxazine Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH), a leading late-stage pharmaceutical company, has recently shared its remarkable advancements and financial results for the second quarter of 2025. Focused on addressing unmet medical needs in central nervous system (CNS), inflammatory, and cardiometabolic...

Continue Reading
PAG Companies Expands Book Sales with Amazon Partnership

Updated Category News Views 169

PAG Companies Enhances Book Sales Via Amazon Exciting New Partnership Recently, PAG Companies, LLC announced a significant enhancement to its book sales strategy by partnering with Amazon, marking a new chapter for the company's retail operations. This announcement was made by Mr. Anthony Wright, the company's CEO, who highlighted the promising advantages of this...

Continue Reading